@elevatemd's perimenopause anxiety claims, fact-checked
Quick answer
Perimenopause-associated anxiety has a recognized biological basis in declining progesterone and its downstream effects on GABA-A receptor signaling via allopregnanolone, making it a legitimate target for hormone therapy evaluation. L-theanine and magnesium glycinate carry modest evidence for anxiety symptom support but are not pharmacologically equivalent to prescription anxiolytics, and the claim that progesterone decline begins at age 25 misrepresents when clinically significant perimenopausal hormonal disruption typically occurs. Women experiencing anxiety, insomnia, or palpitations in the context of menstrual irregularity should seek evaluation that includes hormonal assessment rather than relying solely on supplement protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @elevatemd actually say?
The creator offered three "science-backed" fixes for perimenopause anxiety: L-theanine combined with magnesium glycinate (called "literally nature Xanax"), holding an ice pack on your neck or chest for 10-15 minutes to activate the vagus nerve, and progesterone therapy. She also claimed progesterone production starts declining "around the age of 25" and that these hacks address heart palpitations, insomnia, and what she called "internal trimmers" (likely internal tremors). The tone was personal and enthusiastic, leaning on self-reported experience as much as science. Worth noting upfront: personal testimony is not the same as evidence, and "science-backed" gets used loosely on TikTok health content.
Does the science back this up?
Partially, yes. L-theanine and magnesium glycinate both have legitimate supporting research, though neither is remotely comparable to a benzodiazepine. Vagal cold stimulation has real physiological backing. Progesterone's role in anxiety during perimenopause is well-supported but more complicated than presented here.
L-theanine, an amino acid found in green tea, has demonstrated anxiolytic effects in multiple small trials. Hidese et al. (2019, Nutrients) found that 200mg daily reduced stress and anxiety in healthy adults. Magnesium glycinate's calming effects relate to magnesium's role in GABA receptor modulation. A 2017 systematic review by Boyle et al. (Nutrients) confirmed magnesium supplementation showed benefit for subjective anxiety in mild-to-moderate cases. These are real effects. They are not Xanax effects.
Cold stimulation of the vagus nerve is supported by research on the diving reflex and vagal tone. Jungmann et al. (2018, Applied Psychophysiology and Biofeedback) showed cold water face immersion reduced acute stress markers. Holding an ice pack on your neck is a diluted version of this, but the underlying mechanism is credible.
Progesterone's anxiolytic properties are tied to its conversion to allopregnanolone, a GABA-A receptor positive modulator. Freeman et al. (2001, Menopause) and subsequent work have confirmed that falling progesterone during perimenopause disrupts GABAergic signaling, contributing to anxiety and sleep disruption. The hormone claim has the strongest clinical grounding of the three.
What did they get wrong (or right)?
The "nature Xanax" framing is the biggest problem here. Benzodiazepines act directly and powerfully on GABA-A receptors. L-theanine and magnesium influence mood through indirect, modest pathways. Calling this combination "nature Xanax" sets expectations that the evidence cannot support and could discourage someone from seeking actual treatment for a serious anxiety disorder.
The progesterone decline claim is also off. The creator says progesterone "starts to naturally decline around the age of 25." This conflates peak fertility with clinically meaningful hormonal decline. Progesterone does fluctuate across the menstrual cycle throughout reproductive years, and some research notes a gradual shift in luteal phase progesterone in the late 30s. But framing 25 as the starting point for decline that warrants supplementation is misleading. The Endocrine Society places perimenopause-related hormone disruption typically in the mid-to-late 40s for most women.
- L-theanine and magnesium glycinate: real supporting evidence, overclaimed as "nature Xanax." Rating: mostly accurate.
- Ice pack vagus nerve hack: plausible mechanism, limited direct evidence for this specific application. Rating: mostly accurate.
- Progesterone therapy for anxiety: well-supported in perimenopause, but "I would not survive without it" is anecdote, not protocol. Rating: accurate in context, but framing is imprecise.
- Progesterone declining at 25: misleading. The clinical decline relevant to perimenopause symptoms is not typically a 25-year-old's concern.
What should you actually know?
If your anxiety is spiking in your 40s and your cycle is changing, hormonal contributions are absolutely real and worth discussing with a clinician. The research on allopregnanolone and GABAergic signaling gives perimenopause-related anxiety a solid biological explanation. This is not "in your head," and the creator is right to validate that.
But the gap between "these supplements helped me" and "these are science-backed treatments for your anxiety" is significant. L-theanine and magnesium are low-risk, reasonably evidenced options for mild anxiety support. They are not substitutes for evaluation of a clinical anxiety disorder, thyroid dysfunction, or other conditions that can mimic or worsen in perimenopause.
Progesterone therapy, specifically micronized progesterone, is an FDA-recognized treatment used within hormone therapy regimens. It is not something to start based on a TikTok video. Dose, formulation, and whether you need it at all depend on your specific hormonal picture. A telehealth provider or OB-GYN familiar with menopause medicine can order relevant labs and walk through your options. The Menopause Society (formerly NAMS) publishes evidence-based guidelines that are worth reading if you want to go into that conversation informed.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @elevatemd's perimenopause anxiety claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@elevatemd's perimenopause anxiety claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Perimenopause-associated anxiety has a recognized biological basis in declining progesterone and its downstream effects on GABA-A receptor signaling via allopregnanolone, making it a legitimate target for hormone therapy evaluation.
FormBlends verdict
Perimenopause-associated anxiety has a recognized biological basis in declining progesterone and its downstream effects on GABA-A receptor signaling via allopregnanolone, making it a legitimate target for hormone therapy evaluation. L-theanine and magnesium glycinate carry modest evidence for anxiety symptom support but are not pharmacologically equivalent to prescription anxiolytics, and the claim that progesterone decline begins at age 25 misrepresents when clinically significant perimenopausal hormonal disruption typically occurs. Women experiencing anxiety, insomnia, or palpitations in the context of menstrual irregularity should seek evaluation that includes hormonal assessment rather than relying solely on supplement protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Perimenopause-associated anxiety has a recognized biological basis in declining progesterone and its downstream effects on GABA-A receptor signaling via allopregnanolone, making it a legitimate target for hormone therapy evaluation. L-theanine and magnesium glycinate carry modest evidence for anxiety symptom support but are not pharmacologically equivalent to prescription anxiolytics, and the claim that progesterone decline begins at age 25 misrepresents when clinically significant perimenopausal hormonal disruption typically occurs. Women experiencing anxiety, insomnia, or palpitations in the context of menstrual irregularity should seek evaluation that includes hormonal assessment rather than relying solely on supplement protocols.
- L-theanine at 200mg daily reduced anxiety scores in a 2019 randomized controlled trial (Hidese et al., Nutrients), but its effect size is modest and not comparable to benzodiazepine pharmacology.
- Magnesium deficiency is common and associated with anxiety; a 2017 systematic review (Boyle et al., Nutrients) supports supplementation for mild-to-moderate anxiety, particularly in deficient individuals.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- L-theanine at 200mg daily reduced anxiety scores in a 2019 randomized controlled trial (Hidese et al., Nutrients), but its effect size is modest and not comparable to benzodiazepine pharmacology.
- Magnesium deficiency is common and associated with anxiety; a 2017 systematic review (Boyle et al., Nutrients) supports supplementation for mild-to-moderate anxiety, particularly in deficient individuals.
- Cold stimulation activates the vagus nerve via the diving reflex, a mechanism supported in research, though studies typically use face immersion rather than a neck ice pack.
- Progesterone converts to allopregnanolone, a GABA-A receptor modulator; declining levels in perimenopause have a documented link to anxiety and sleep disruption in peer-reviewed menopause literature.
- The claim that progesterone declines at age 25 conflates normal luteal phase variation with perimenopausal hormonal disruption, which the Endocrine Society associates with the mid-to-late 40s for most women.
- Perimenopause anxiety can overlap with thyroid dysfunction, clinical anxiety disorders, and cardiovascular causes of palpitations; supplement protocols should not replace a differential diagnosis.
- The Menopause Society (NAMS) publishes annually updated evidence-based guidelines on hormone therapy that are freely accessible and a more reliable reference than social media content.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
ElevateMD · TikTok creator
55.2K views on this video
If you’re in #perimemopause , & your anxiety is off the charts…THIS VIDEO IS FOR YOU! 🫵🏻🥹 Anxiety is one of the most common symptoms we hear from our perimenopause & menopause patients. But you’ll
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ElevateMD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.